Cerenion awarded second patent on its C-TREND® technology in China

The National Intellectual Property Administration of the P.R.C. (CNIPA) has awarded Cerenion its second patent on C-Trend® in China.
The patent is second in China and eight in total.
The EEG signal is processed by the C-Trend Index algorithm in C-Trend technology to produce the C-Trend Index, which is a single number. The Index is a single value between 0 and 100 that describes the patient's EEG slow wave activity. Slow wave activity, which takes place during sedation and deep sleep, is crucial for a healthy brain. The patent gives protection to this EEG's slow-wave activity that is utilized in the C-Trend index, which can be used to assess the brain activity of an unconscious patient, especially after cardiac arrest.
Cerenion C-Trend technology has been granted patents in the United States, The European Union, Japan, and China and multiple intellectual property applications have been filed worldwide.
Visit us
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
Cerenion Oy
Kyllikinportti 2
00240 Helsinki
Contact us
Call us: +358 50 447 4909
E-mail us:
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2024 Cerenion Oy